JP2015522272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522272A5 JP2015522272A5 JP2015519306A JP2015519306A JP2015522272A5 JP 2015522272 A5 JP2015522272 A5 JP 2015522272A5 JP 2015519306 A JP2015519306 A JP 2015519306A JP 2015519306 A JP2015519306 A JP 2015519306A JP 2015522272 A5 JP2015522272 A5 JP 2015522272A5
- Authority
- JP
- Japan
- Prior art keywords
- motomeko
- salts
- toxoid
- capsular polysaccharide
- conjugate obtained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 21
- 239000000427 antigen Substances 0.000 claims 8
- 102000036639 antigens Human genes 0.000 claims 8
- 108091007433 antigens Proteins 0.000 claims 8
- 150000004676 glycans Chemical class 0.000 claims 7
- 229920001282 polysaccharide Polymers 0.000 claims 7
- 239000005017 polysaccharide Substances 0.000 claims 7
- 201000005702 Pertussis Diseases 0.000 claims 6
- 229960000814 tetanus toxoid Drugs 0.000 claims 6
- 229960003983 diphtheria toxoid Drugs 0.000 claims 5
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 4
- 229940024606 amino acid Drugs 0.000 claims 4
- 229950003776 protoporphyrin Drugs 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- 102000014914 Carrier Proteins Human genes 0.000 claims 3
- 108010078791 Carrier Proteins Proteins 0.000 claims 3
- 101710154643 Filamentous hemagglutinin Proteins 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 229960003067 cystine Drugs 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- 239000011782 vitamin Substances 0.000 claims 3
- 229940088594 vitamin Drugs 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 2
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 claims 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- 241000991587 Enterovirus C Species 0.000 claims 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- 206010043376 Tetanus Diseases 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- 239000012228 culture supernatant Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 206010013023 diphtheria Diseases 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical group OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 2
- 238000003306 harvesting Methods 0.000 claims 2
- 208000002672 hepatitis B Diseases 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims 2
- 239000003002 pH adjusting agent Substances 0.000 claims 2
- 108010021711 pertactin Proteins 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000006228 supernatant Substances 0.000 claims 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 2
- 229940035893 uracil Drugs 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 1
- 201000006082 Chickenpox Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 108010024636 Glutathione Proteins 0.000 claims 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical group SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 1
- 241000588650 Neisseria meningitidis Species 0.000 claims 1
- 208000000474 Poliomyelitis Diseases 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 1
- 241000702670 Rotavirus Species 0.000 claims 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 206010046980 Varicella Diseases 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 239000000337 buffer salt Substances 0.000 claims 1
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 229960002173 citrulline Drugs 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- 230000001268 conjugating effect Effects 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Chemical group SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 235000004554 glutamine Nutrition 0.000 claims 1
- 229960003180 glutathione Drugs 0.000 claims 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 159000000014 iron salts Chemical class 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 159000000003 magnesium salts Chemical class 0.000 claims 1
- 150000002696 manganese Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000010805 mumps infectious disease Diseases 0.000 claims 1
- 229940055726 pantothenic acid Drugs 0.000 claims 1
- 235000019161 pantothenic acid Nutrition 0.000 claims 1
- 239000011713 pantothenic acid Substances 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- 229960002477 riboflavin Drugs 0.000 claims 1
- 235000019192 riboflavin Nutrition 0.000 claims 1
- 239000002151 riboflavin Substances 0.000 claims 1
- 125000001452 riboflavin group Chemical group 0.000 claims 1
- 201000005404 rubella Diseases 0.000 claims 1
- 125000005629 sialic acid group Chemical group 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 235000019157 thiamine Nutrition 0.000 claims 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- 239000011721 thiamine Substances 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 150000003751 zinc Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1256329 | 2012-07-02 | ||
| FR1256329A FR2992656B1 (fr) | 2012-07-02 | 2012-07-02 | Procede de production d'antigenes haemophilus influenzae type b |
| PCT/FR2013/051549 WO2014006318A1 (fr) | 2012-07-02 | 2013-07-02 | Procédé de production d'antigènes haemophilus influenzae type b |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015522272A JP2015522272A (ja) | 2015-08-06 |
| JP2015522272A5 true JP2015522272A5 (https=) | 2016-08-12 |
| JP6347778B2 JP6347778B2 (ja) | 2018-06-27 |
Family
ID=47666183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015519306A Active JP6347778B2 (ja) | 2012-07-02 | 2013-07-02 | ヘモフィルス・インフルエンザｂ型菌抗原の生成方法 |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US9556464B2 (https=) |
| EP (1) | EP2885397B1 (https=) |
| JP (1) | JP6347778B2 (https=) |
| KR (1) | KR102051482B1 (https=) |
| CN (1) | CN104583390B (https=) |
| AU (1) | AU2013285306B2 (https=) |
| BR (1) | BR112014033082B1 (https=) |
| CA (1) | CA2878053C (https=) |
| CR (1) | CR20140559A (https=) |
| CY (1) | CY1120465T1 (https=) |
| DK (1) | DK2885397T3 (https=) |
| ES (1) | ES2681993T3 (https=) |
| FR (1) | FR2992656B1 (https=) |
| GE (1) | GEP201706788B (https=) |
| HR (1) | HRP20181206T1 (https=) |
| HU (1) | HUE038865T2 (https=) |
| IL (1) | IL236208A0 (https=) |
| LT (1) | LT2885397T (https=) |
| MX (1) | MX358953B (https=) |
| NZ (1) | NZ702471A (https=) |
| PE (1) | PE20150192A1 (https=) |
| PH (1) | PH12014502730A1 (https=) |
| PL (1) | PL2885397T3 (https=) |
| PT (1) | PT2885397T (https=) |
| RS (1) | RS57495B1 (https=) |
| RU (1) | RU2644246C2 (https=) |
| SG (1) | SG11201408194SA (https=) |
| SI (1) | SI2885397T1 (https=) |
| SM (1) | SMT201800389T1 (https=) |
| TR (1) | TR201810678T4 (https=) |
| UA (1) | UA115787C2 (https=) |
| WO (1) | WO2014006318A1 (https=) |
| ZA (2) | ZA201500028B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2624014C1 (ru) * | 2016-04-08 | 2017-06-30 | Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства России (ФГУП СПбНИИВС ФМБА России) | Штамм haemophilus influenzae spb тип в - высокоактивный продуцент капсульного полисахарида полирибозилрибитолфосфата |
| CN109922828A (zh) | 2016-10-20 | 2019-06-21 | Km生物医药股份公司 | 使用具有降低了的分子量的PRP的Hib结合疫苗的制造方法 |
| WO2018193475A2 (en) * | 2017-04-22 | 2018-10-25 | Biological E Limited | An improved method for high level production of crm |
| RU2704452C1 (ru) * | 2019-04-22 | 2019-10-28 | Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства | Способ получения вакцины гемофильной тип b конъюгированной |
| CN109975559B (zh) * | 2019-04-29 | 2023-07-11 | 厦门稀土材料研究所 | 一种时间分辨荧光定量检测25羟基维生素d的试剂盒及方法 |
| CN111000994A (zh) * | 2019-12-26 | 2020-04-14 | 北京科兴中维生物技术有限公司 | 一种液体疫苗组合物及其制备方法与应用 |
| CN112212779B (zh) * | 2020-09-04 | 2022-05-17 | 厦门大学 | 一种水凝胶柔性应变传感器的制备方法 |
| WO2022114735A1 (ko) * | 2020-11-25 | 2022-06-02 | 주식회사 엘지화학 | 헤모필루스 인플루엔자 타입 b의 prp 항원 정제 공정의 품질 평가 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03183416A (ja) * | 1989-12-12 | 1991-08-09 | Shozo Oyama | 菌根菌を培養する方法、およびその子実体を取得する方法 |
| FR2791895B1 (fr) * | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| RU2258737C2 (ru) * | 2003-09-01 | 2005-08-20 | Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН | Питательная среда для культивирования бактерий haemophilus influenzae типа b |
| FR2914302A1 (fr) * | 2007-03-30 | 2008-10-03 | Sanofi Pasteur Sa | Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese |
| FR2918671B1 (fr) * | 2007-07-10 | 2010-10-15 | Sanofi Pasteur | Milieu de culture d'haemophilus influenzae type b. |
| GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
| PE20100366A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
| TW201129698A (en) * | 2009-12-10 | 2011-09-01 | Jgc Corp | New cell culture method |
-
2012
- 2012-07-02 FR FR1256329A patent/FR2992656B1/fr active Active
-
2013
- 2013-07-02 BR BR112014033082-4A patent/BR112014033082B1/pt active IP Right Grant
- 2013-07-02 RU RU2015103140A patent/RU2644246C2/ru active
- 2013-07-02 CN CN201380035582.0A patent/CN104583390B/zh active Active
- 2013-07-02 PE PE2014002572A patent/PE20150192A1/es not_active Application Discontinuation
- 2013-07-02 TR TR2018/10678T patent/TR201810678T4/tr unknown
- 2013-07-02 NZ NZ702471A patent/NZ702471A/en unknown
- 2013-07-02 HU HUE13744668A patent/HUE038865T2/hu unknown
- 2013-07-02 SI SI201331114T patent/SI2885397T1/sl unknown
- 2013-07-02 PT PT137446688T patent/PT2885397T/pt unknown
- 2013-07-02 SM SM20180389T patent/SMT201800389T1/it unknown
- 2013-07-02 CA CA2878053A patent/CA2878053C/fr active Active
- 2013-07-02 KR KR1020157002676A patent/KR102051482B1/ko active Active
- 2013-07-02 WO PCT/FR2013/051549 patent/WO2014006318A1/fr not_active Ceased
- 2013-07-02 ES ES13744668.8T patent/ES2681993T3/es active Active
- 2013-07-02 LT LTEP13744668.8T patent/LT2885397T/lt unknown
- 2013-07-02 RS RS20180874A patent/RS57495B1/sr unknown
- 2013-07-02 US US14/411,241 patent/US9556464B2/en active Active
- 2013-07-02 PL PL13744668T patent/PL2885397T3/pl unknown
- 2013-07-02 JP JP2015519306A patent/JP6347778B2/ja active Active
- 2013-07-02 EP EP13744668.8A patent/EP2885397B1/fr active Active
- 2013-07-02 DK DK13744668.8T patent/DK2885397T3/en active
- 2013-07-02 GE GEAP201313708A patent/GEP201706788B/en unknown
- 2013-07-02 SG SG11201408194SA patent/SG11201408194SA/en unknown
- 2013-07-02 AU AU2013285306A patent/AU2013285306B2/en active Active
- 2013-07-02 UA UAA201500772A patent/UA115787C2/uk unknown
- 2013-07-02 MX MX2014014607A patent/MX358953B/es active IP Right Grant
- 2013-07-02 HR HRP20181206TT patent/HRP20181206T1/hr unknown
-
2014
- 2014-12-04 CR CR20140559A patent/CR20140559A/es unknown
- 2014-12-05 PH PH12014502730A patent/PH12014502730A1/en unknown
- 2014-12-11 IL IL236208A patent/IL236208A0/en active IP Right Grant
-
2015
- 2015-01-05 ZA ZA2015/00028A patent/ZA201500028B/en unknown
- 2015-01-05 ZA ZA2015/00014A patent/ZA201500014B/en unknown
-
2016
- 2016-12-16 US US15/381,436 patent/US10144940B2/en active Active
-
2018
- 2018-07-25 CY CY20181100777T patent/CY1120465T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015522272A5 (https=) | ||
| RU2015103140A (ru) | Способ получения антигенов haemophilus influenzae типа в | |
| AU2018302767B2 (en) | An immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof | |
| RU2013136397A (ru) | Комбинированная семивалентная вакцина | |
| HRP20110431T1 (hr) | Kombinirano cjepivo od inaktiviranog poliovirusa | |
| JP2008525423A5 (https=) | ||
| RU2007127993A (ru) | Сахарид-конъюгатные вакцины | |
| JP2012506421A5 (https=) | ||
| CA3005308A1 (en) | Media and fermentation methods for producing polysaccharides in bacterial cell culture | |
| JP2004505992A5 (https=) | ||
| JP2024009899A (ja) | 多価ワクチン組成物 | |
| JP2022502469A (ja) | 低減用量の不活化ポリオウイルスを含む混合ワクチン組成物およびそれを調製するための方法 | |
| JP2019526635A5 (https=) | ||
| JP6385441B2 (ja) | ボルデテラ属種の工業規模培養のための合成培地 | |
| JP2008536515A5 (https=) | ||
| RU2014147491A (ru) | Антигены и антигенные композиции | |
| US11793869B2 (en) | Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof | |
| HK1208493B (zh) | 用於生产b型流感嗜血杆菌抗原的方法 | |
| OA20569A (en) | Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof. |